Effect of metformin and insulin combination on monocyte chemoattractant protein-1 and cathepsin-D in type 2 diabetes mellitus
- 25 August 2020
- journal article
- research article
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (6), 1703-1710
- https://doi.org/10.1016/j.dsx.2020.08.016
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Association between new onset diabetic retinopathy and monocyte chemoattractant protein-1 (MCP-1) polymorphism in Japanese type 2 diabetesDiabetes Research and Clinical Practice, 2015
- Chemokine Mediated Monocyte Trafficking into the Retina: Role of Inflammation in Alteration of the Blood-Retinal Barrier in Diabetic RetinopathyPLOS ONE, 2014
- Pathophysiology of Diabetic RetinopathyISRN Ophthalmology, 2013
- Effect of Metformin Glycinate on Glycated Hemoglobin A1c Concentration and Insulin Sensitivity in Drug-Naive Adult Patients with Type 2 Diabetes MellitusDiabetes Technology & Therapeutics, 2012
- Prolactin and vasoinhibins: Endogenous players in diabetic retinopathyIUBMB Life, 2011
- The Effect of Oral Antidiabetic Agents on A1C LevelsDiabetes Care, 2010
- Cathepsin D—Many functions of one aspartic proteaseCritical Reviews in Oncology/Hematology, 2008
- Monocyte chemoattractant protein-1–induced angiogenesis is mediated by vascular endothelial growth factor-ABlood, 2005
- Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosisOncogene, 2002
- Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.Proceedings of the National Academy of Sciences of the United States of America, 1994